C. difficile cases increase by one-third over three years, government data show Data from the UK Health Security Agency (UKHSA) show that a three-year increase in Clostridioides difficile infections in England was observed across all seven UKHSA regions.…
How prescribing pharmacists can make an impact in the emergency department A prescribing pharmacist details his experience with bringing medicines expertise to an emergency department resuscitation team.…
Almost 80% of pharmacies receive inappropriate antibiotic requests every day, reveals survey The majority of pharmacies surveyed by the National Pharmacy Association also said they were worried that demand for antibiotics for minor ailments “posed a serious risk to patient safety”.…
Continuity of care and reducing risk during transitions of care This article considers the evidence of interventions to reduce risk during transitions of care and explains best practice for pharmacy teams.…
Pancreatic exocrine insufficiency: causes, diagnosis and treatment An overview of the causes, diagnosis and treatments for pancreatic exocrine insufficiency, including a case study of a patient’s experience.…
New antibiotic already causing AMR concerns, study results suggest Researchers also found that ceftazidime with avibactam-resistant bacteria coincided with the presence of carbapenemase genes.…
Smoking cessation drug could help young people quit vaping, study results suggest Researchers found that varenicline is an effective vaping cessation drug among participants aged 16–25 years who vape nicotine daily or near daily.…
Neonatal sepsis: prevention and management The third article in a series on complications associated with prematurity and unwell neonates.…
NICE reverses draft guidance to recommend targeted therapy for patients with advanced bowel cancer The National Institute for Health and Care Excellence said the treatment should be available on the NHS after the manufacturer provided additional clinical evidence.…
Antibiotic could help tackle drug-resistant gonorrhoea, study results suggest Researchers found that gepotidacin was as effective as the current recommended first-line therapy for gonorrhoea.…
